Article
Molecular and structural characterization of lenalidomide-mediated sequestration of eIF3i
2022-08-04
Abstract excerpt
<h4>ABSTRACT</h4> Lenalidomide is a ligand of the E3 ligase substrate adaptor cereblon (CRBN) that achieves its clinical effects in part by promotion of substrate recruitment and degradation. In contrast to prior substrates, eIF3i is recruited but not degraded upon complex formation with lenalidomide and CRBN, although the structural details and mechanistic outcomes of this interaction are unresolved. Here, we ch...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b05ac4ac-2208-5948-9509-b67b5f09081e
- DOI
- 10.1101/2022.08.03.502648
